WCM
CTSO icon

Wealthcare Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Wealthcare Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-9,269
Closed -$122K – 490
2015
Q1 		$122K Buy
+9,269
New +$95.4K 0.01% 136

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

Wealthcare Capital Management's CTSO Position: Q2 2015 in Review

Wealthcare Capital Management sold out of Cytosorbents Corp (CTSO) in Q2 2015, closing a stake of 9,269 shares — an estimated $122K sold.

Wealthcare Capital Management first reported a position in CTSO in Q1 2015 and held it in 1 quarter. The position peaked at $122K in Q1 2015. 31 funds tracked by Wall St. Rank hold CTSO as of Q2 2015.

  • Wealthcare Capital Management reported no remaining Cytosorbents Corp position as of Q2 2015 after selling out during the quarter.
  • Wealthcare Capital Management sold 9,269 Cytosorbents Corp shares in Q2 2015, an estimated $122K.
  • Wealthcare Capital Management first reported a position in Cytosorbents Corp in Q1 2015 and held it in 1 quarter.
  • Wealthcare Capital Management's Cytosorbents Corp position peaked at $122K in Q1 2015.
  • 31 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2015.

Based on Wealthcare Capital Management's 13F filing for Q2 2015, filed 24 Aug 2015.